Company profile: Ajinomoto Bio-Pharma Services
1.1 - Company Overview
Company description
- Provider of manufacturing and process development services, covering small molecule API and intermediate production from pre-clinical to commercialization, large molecule biologics with microbial cell banking and expression systems, high potency and ADC manufacturing with GLP bioconjugation, oligonucleotide and peptide synthesis (solid phase, Ajiphase), and drug product formulation, fill finish, packaging, and storage.
Products and services
- Drug Product Manufacturing: Produces commercial-scale drug products with integrated formulation, fill-finish operations, packaging, and storage, coordinating these steps to deliver consistent finished product
- Small Molecule Manufacturing: Engineers preclinical-to-commercial small-molecule APIs and intermediates, conducting production across pre-clinical to commercialization stages for seamless progression of materials
- Large Molecule Manufacturing: Constructs microbial-based large-molecule biologics using microbial cell banking and expression systems to deliver consistent biologic production
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ajinomoto Bio-Pharma Services
ProSciento
HQ: United States
Website
- Description: Provider of clinical research and development services, leveraging broad scientific expertise, direct patient access, advanced methodologies, and integrated operations to advance science and achieve quality results through client and partner connections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ProSciento company profile →
Aiolos Bio
HQ: United States
Website
- Description: Provider of therapies for respiratory and immune conditions, initially advancing AIO-001, a monoclonal antibody for moderate-to-severe asthma dosed every 6 months. Offers vaccines for meningitis, shingles, RSV, flu, and polio; specialty and general medicines for HIV, asthma, COPD, lupus, cancer, and skin diseases; conducts infectious disease research and develops respiratory/immunology solutions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aiolos Bio company profile →
TCG Supplies
HQ: United States
Website
- Description: Provider of clinical trial materials management and centralized randomization services for the pharmaceutical research industry worldwide, including preparation and packaging/labeling of trial materials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TCG Supplies company profile →
Veranova
HQ: United States
Website
- Description: Provider of research, development, and manufacturing of sophisticated, complex active pharmaceutical ingredients (APIs) for pharmaceutical and biotech industries, applying scientific expertise and diversified talent to create fresh approaches to resolving business issues and enhancing stakeholder value.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Veranova company profile →
PharmaSeek
HQ: United States
Website
- Description: Provider of consulting and training solutions for clinical research sites, helping institutions, investigators, and independent sites decrease study start-up timelines by assuming administrative burdens of research management, including study identification, contract and budget negotiation, coverage analysis, and financial management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaSeek company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ajinomoto Bio-Pharma Services
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ajinomoto Bio-Pharma Services
2.2 - Growth funds investing in similar companies to Ajinomoto Bio-Pharma Services
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ajinomoto Bio-Pharma Services
4.2 - Public trading comparable groups for Ajinomoto Bio-Pharma Services
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →